No Data
No Data
Jindike (688670.SH): The controlling shareholder and joint actual controller renewed the joint control and concerted action agreement.
On July 25th, Gelunhui announced that on July 25th, 2024, the company received a notification from the company's controlling shareholder and co-controlling shareholder, Mr. Yu Jun and Mr. Zhang Liangbin, regarding the renewal of the "Joint Control and Consistent Action Agreement for Jiangsu Jindike Biotechnology Co., Ltd." (hereinafter referred to as the "Consistent Action Agreement"). The "Joint Control and Consistent Action Agreement" and the "Supplementary Agreement to the Joint Control and Consistent Action Agreement" signed by both parties before the company's initial public offering of stocks will expire on August 1st, 2024, for the development needs of the company's future.
Jindike (688670.SH): 79.0644 million restricted shares will be released on August 2.
On July 25th, Gelunhui reported that the total number of stocks listed for Jindike (688670.SH) was 79.0644 million. The date of the stock listing is August 2, 2024.
Jindike (688670.SH): Starting from June 12th, the prices of the quadrivalent influenza vaccine products will be adjusted.
On June 12th, Gelunhui announced that, based on the current market situation and the overall competitive landscape of the industry, and after careful consideration, the company has decided to adjust the price of its quadrivalent influenza vaccine products starting from June 12, 2024: the quadrivalent influenza split virus vaccine (adult formulation, pre-filled 0.5ml/syringe) will be adjusted to 88 yuan/syringe; the quadrivalent influenza split virus vaccine (adult formulation, vial 0.5ml/bottle) will be adjusted to 85 yuan/bottle. The above product prices do not include storage and transportation fees. If vaccine storage and transportation fees are charged in some areas, the quoted price will be adjusted accordingly.
Recent 18% Pullback Would Hurt Jiangsu Gdk Biological Technology Co., Ltd (SHSE:688670) Insiders
Jindick (688670.SH): Net loss of 21.494 million yuan in the first quarter
On April 15, Ge Longhui (688670.SH) released its report for the first quarter of 2024. During the reporting period, it achieved operating income of 50,181 million yuan, a year-on-year decrease of 95.28%; net profit attributable to shareholders of listed companies - 21.494 million yuan; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss - 244.23,500 yuan; and basic earnings per share - 0.17 yuan.
Jindick (688670.SH) reported 2023 annual results, with a net loss of 70.993 million yuan, which changed from profit to loss over the previous year
According to Zhitong Finance App News, Jindick (688670.SH) released its 2023 annual report. During the reporting period, the company achieved operating income of 135 million yuan, a year-on-year decrease of 57.74%; net loss attributable to shareholders of listed companies was 72.503 million yuan, which changed from profit to loss; net loss attributable to shareholders of listed companies was deducted from non-recurring profit and loss of 72.579 million yuan, year-on-year from profit to loss; basic loss per share was 0.58 yuan/share. During the reporting period, operating revenue decreased by 57.74% compared to the same period last year, mainly due to the temporary suspension of production due to a sudden heavy rain in Taizhou, where the company is located in July 2023, until
No Data